Trials / Unknown
UnknownNCT05973474
The Atherogenic Index of Plasma(AIP) in Patients With Atrial Fibrillation
Prognostic Value of the Atherogenic Index of Plasma(AIP)for Cardiovascular Outcomes in Patients With Atrial Fibrillation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to learn about The Atherogenic Index of Plasma(AIP) in patients with atrial fibrillation(AF). The main questions it aims to answer are: (1)To investigate the correlation between AIP and the occurrence rate of AF. (2) To investigate the correlation between AIP and the occurrence rate of cardiovascular outcome events (MACE events, heart failure, embolism events) in patients with AF. Patients's clinical data including medical history, laboratory tests, and imageological examination will be collected and further analysed.
Detailed description
Baseline demographic data: age, gender, height, weight, systolic blood pressure, diastolic blood pressure, smoking habit, drinking habit, physical activity, fasting blood glucose, medication use (statins, ACEI/ARB, anticoagulant related drugs), basic medical history (hypertension, diabetes mellitus, coronary heart disease).
Conditions
Timeline
- Start date
- 2023-07-30
- Primary completion
- 2024-03-01
- Completion
- 2024-07-01
- First posted
- 2023-08-03
- Last updated
- 2023-08-03
Source: ClinicalTrials.gov record NCT05973474. Inclusion in this directory is not an endorsement.